Radvax

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameRadvax

Drug Alias NameAutologous tumor vaccine conjugated to Advax adjuvant (Vaxine/University of Sydney)next generation vaccine (Vaxine/University of Sydney)Autologous tumour vaccine

ClassificationCell and gene therapy > Cell therapyVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsSolid tumoursLymphomaNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesVaxine Pty Ltd

China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Sydney Vaxine Pty Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumoursLymphoma

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A